Objective: Poor descriptions of standard care may compromise interpretation of results in randomised controlled trials (RCTs) of health interventions. We investigated quality of standard care in RCTs of behaviour change interventions for young people with type 1 diabetes and consider implications for evaluating trial outcomes. Design: We conducted systematic searches for articles published between 1999 and 2012. We extracted standard care descriptions and contacted trial authors to complete a checklist of standard care activities. The relationship between standard care quality and outcomes was examined via subgroup meta-analyses and meta-regression. Main outcome measures: Standard care descriptions, standard care quality, and relationships between standard care quality with medical and psychological outcomes. Results: We identified 20 RCTs described across 26 articles. Published descriptions of standard care were limited to service-level features. Author responses indicated standard care provision extended beyond published accounts. Subgroup analyses suggested control groups receiving higher standard care quality showed larger improvements in both medical and psychological outcomes, although standard care quality did not predict outcomes significantly. Conclusion: The quality of care delivered to control group participants can influence outcomes of RCTs. Inadequate reporting exacerbates this issue by masking variations between trials. We argue for increased clarity in reporting standard care in future trials.
Introduction
Randomised controlled trials (RCTs) are generally considered to represent the gold standard for evaluating health care interventions (Coates, 2010) . By definition, such trials involve the comparison of outcomes between two or more groups (usually an intervention vs. a control), meaning the relative efficacy of the control condition plays an integral part in determining the effect size associated with the intervention under examination (Au, Castro, & Krishnan, 2007) . In RCTs of health care interventions, standard care (also known as treatment-as-usual, usual care or routine care) is frequently employed as the control condition to establish if the intervention is a significant improvement over existing practice (Freedland, Mohr, Davidson, & Schwartz, 2011) . This research design allows a direct comparison between current and an alternative practice, and thus allows policy-makers to judge the appropriateness of innovations in health care (e.g. through economic evaluations, see Evers, Hiligsmann, & Adarkwah, 2015) .
However, the use of standard care control groups has been the subject of much debate; with many pointing out that what constitutes standard care is rarely clear (Burns, 2009; Dawson et al., 2009; Freedland et al., 2011; Mohr et al., 2009; Thompson & Schoenfeld, 2007) . Freedland et al. (2011) noted that two trials may include a standard care condition, but this implies few similarities beyond their names. Indeed, standard care has been shown to vary even for the same disease or condition (Burns et al., 2007; de Bruin, Viechtbauer, Hospers, Schaalma, & Kok, 2009) . This is perhaps unsurprising as health care provision and spending can differ between countries (Anderson, Reinhardt, Hussey, & Petrosyan, 2003) , updated guidelines and technologies are introduced at variable rates (Cappellaro, Fattore, & Torbica, 2009) and what is considered to be best practice evolves with new research findings. Therefore, the composition of standard care may considerably differ across hospitals, countries and over time.
This variation in health care practices raises important issues for the interpretation and generalisability of RCTs of health behaviour change interventions; particularly where standard care is used as the control condition. For example, an intervention compared with highly effective standard care practices could yield a lower effect size than the same intervention compared against less-effective care. Unfortunately, as standard care conditions are often inadequately described (Burns, 2009; Mohr et al., 2009) , it is difficult to conclude whether or not a positive trial is the result of an effective intervention or low-efficacy standard care.
Recent research examining interventions to enhance HIV antiretroviral therapy adherence has demonstrated the substantial influence that variation in standard care quality can have on control group outcomes (de Bruin et al., 2009) . This, in turn, can distort effect sizes and lead to inaccurate conclusions when synthesising the findings from multiple RCTs (de Bruin et al., 2010) . As a result, there are calls for standard care quality to be assessed and reported in future RCTs allowing for control of this in meta-analyses (de Bruin et al., 2009 (de Bruin et al., , 2010 .
A similar problem in terms of variation in standard care quality potentially affects trials involving young people with type 1 diabetes. Given the complex nature of diabetes self-management and the necessity for a high level of patient involvement in daily care, the composition of standard care is likely to involve a range of behaviour change techniques that may impact on both medical and psychological outcomes. In this paper, we examine recent behaviour change interventions for young people with type 1 diabetes to determine i) the information provided about standard care control conditions in published articles; ii) standard care quality across trials via author completed checklists; and iii) the influence of standard care quality on medical and psychological outcomes in control groups in these interventions.
Method
Literature search and selection procedure Systematic searches of electronic databases (MEDLINE, Web of Knowledge, PsycINFO, CINHAL, Embase, ProQuest, and Cochrane database of systematic reviews and Conference proceedings citation index) were conducted to identify RCTs of behaviour change interventions, published between July 1999 and November 2012, for young people with type 1 diabetes. Search terms were variants on: type 1 diabetes, psychological interventions and RCTs (see supplementary materials). We included trials that involved young people aged 8-21 years, diagnosed with type 1 diabetes for at least 6 months and measured glycated haemoglobin (HbA1c or GhB) or a validated psychological measure. Non-English language articles and samples with an additional co-morbid chronic illness were excluded. Reference lists and future citations were also examined for additional articles (i.e. the ancestry approach - Johnson & Eagly, 2000) . The search strategy yielded a total of 32,102 articles from which non-eligible studies were removed using database filters. This left 552 abstracts to be screened with 48 articles extracted for further review. Overall, there was substantial agreement between reviewers (k = .85, p < .001) with 20 RCTs incorporating a standard care control described across 26 published articles included in the review. The flow of information through the review process can be seen in Figure 1 .
Published descriptions of standard care
Published manuscripts were examined individually and any details pertaining to standard care practices in each trial were extracted by two researchers (KA, CE). When multiple articles describing one RCT were present (e.g. follow-up reports), details were collated to establish as much detail as possible about standard care. This means that in the trial led by Wysocki, three articles were consulted (Wysocki, Greco, Harris, Bubb, & White, 2001; Wysocki et al., 1999 Wysocki et al., , 2000 ; in the trial led by Ellis four articles were consulted (Ellis et al., 2005a (Ellis et al., , 2005b Ellis, Yopp, et al., 2007) and in the trial led by de Wit, two articles were consulted (de Wit et al., 2008 (de Wit et al., , 2010 .
Assessment of standard care quality
To assess standard care quality, we adapted a checklist developed for use in highly active antiretroviral therapy adherence trials (de Bruin et al., 2009) . For example, 'feedback of CD4 and viral load' was amended to 'feedback on most recent HbA1c/A1c'. Other inappropriate items were removed. We derived additional activities from descriptions provided in selected articles and discussions with local Diabetes Specialist Nurses. The final checklist consisted of 19 activities (see Table 1 ) which were then classified as behaviour change techniques using the taxonomy described by Michie et al. (2011) . Activities were coded independently by two researchers (KA, CE) with 100% agreement. Potential checklist responses were 'Never', 'For some patients', 'For most patients', 'For all patients' and 'Don't know'.
We derived a summed score for standard care quality for each trial by scoring 'Never' and 'Don't know' responses as 0, 'For some patients' as 1, 'For most patients' as 2 and 'For all patients' as 3. This yielded a theoretical range of 0-57, with higher scores indicating better standard care quality. Additional questions were included to determine the frequency of scheduled appointments, the type of clinic where care was administered (e.g. paediatric, adolescent and adult) and the health professionals involved in care. We contacted primary authors of trials to complete this checklist retrospectively to establish which items were routinely delivered as part of standard care.
Statistical analyses
Effect sizes (d) for glycaemic control (HbA1c or GhB) and psychological outcomes using pre-and post-mean scores, pre-and post-standard deviations and pre/post correlations in the control group were calculated using comprehensive meta-analysis version 2 (Borenstein, Hedges, Higgins, & Rothstein, 2005) . As pre/post control group correlations are rarely reported, we calculated effect sizes and assumed positive correlations of .25, .5 and .75 if the actual value was unknown as described by Norris, Lau, Smith, Schmid, and Engelgau (2002) . As these approaches yielded essentially identical results, the findings reported in this paper are based on a correlation of .5. To assess the internal reliability of the standard care quality checklist we computed Cronbach's alpha. Random effects meta-analyses were run using the metan command on Stata 12.1 (StataCorp, 2012; default settings), with heterogeneity assessed via Cochran's Q test and the I 2 Statistic (Higgins, Thompson, Deeks, & Altman, 2003) . Where heterogeneity was significant, subgroup analyses of high vs. low standard care quality (calculated via a median split) were conducted to give an indication of relative efficacy. Standard care quality was then entered as a main predictor in a mixed-effects meta-regression model (metareg and default settings) both individually and in models containing potential confounding trial features (mean age of participants at baseline, gender, attrition, glycaemic control measure and whether only those with poor glycaemic control were selected), using control group effect sizes as the outcome measure. 
Results
(1) Information provided about standard care control conditions in published articles
Standard care details provided in published articles for each trial are shown in Table 2 . Of the 20 trials, 16 (80%) reported frequency with which patients were seen as part of standard care, which ranged from monthly to every six months. Some details regarding the environment where care was administered were reported in 18 RCTs (90%) with different locations reported across trials. Nine trials (41%) included information about health professionals involved in standard care. There was considerable variety in the make-up of teams involved in standard care, ranging from only paediatricians to large multidisciplinary teams. Additional features of standard care were explicitly reported in a small number of trials. Based on this assessment of published information, we concluded that the information provided about standard care was limited to servicelevel information, and it was not possible to determine the activities and behaviour change techniques delivered to control group participants.
(2) Standard care quality across trials via author completed checklists
Seventeen authors completed and returned the standard care checklist (85% response rate). Of these, 16 reported scheduling contact with patients every 3 months, with one reporting scheduling contact every 6-8 months. The type of clinic where care was administered was variously described as paediatric (n = 11), paediatric and adolescent (n = 5) and adolescent only (n = 1). The number of professionals involved in standard care ranged from 3 to 7 (M = 4.71 ± 1.15). In terms of checklist responses, total standard care activities delivered to all participants ranged from 2 to 15 (M = 9.94 ± 3.96). The majority of authors were aware of standard care practices with relatively few 'Don't Know' responses (never: n = 12; up to 20%: n = 3; between 20 and 40%: n = 2) 1 . Computed scores for standard care quality ranged from 27 to 52 (M = 40.82 ± 7.50; see Figure 2 ) and the checklist as a whole was found to be internally consistent (α = .78).
(3) The influence of standard care quality on medical and psychological control group outcomes
In terms of glycaemic control, 14 trials included sufficient details for inclusion in a meta-analysis. This yielded a total sample of 508 control group participants. Pooling these in a random effects analysis (see Figure 3 ) produced a non-significant overall control group effect size of .07 (95% CI: −.8 to .22). Cochran's Q test revealed significant heterogeneity across trials (Q(13) = 31.85, p = .003) with the I 2 Statistic showing moderate variation (59.2%) in effect sizes attributable to heterogeneity.
Based on a median split, trials with higher standard care quality scores (>42) had a larger pooled effect size (d = .13, 95% CI: −.09 to .35) than those with lower standard care quality (d = .02, 95% CI: −.19 to .21) (see Figure 4) . However, meta-regression analysis revealed standard care quality was not a significant predictor of effect size when considered individually (t = −.31, p > .05) or when considered in models including potentially confounding trial features (mean age of participants at baseline, gender, attrition, glycaemic control measure and whether only those with poor glycaemic control were selected), none of which significantly explained the variation between trials (all p's > .05).
For psychological outcomes, eight trials included sufficient details for inclusion. This yielded a sample of 340 control group participants. A random effects meta-analysis (see Figure 5 ) revealed an overall effect size of .05 (95% CI: −.08 to .17). Psychological outcomes in the control groups were found to be relatively homogenous (Q(7) = 8.72, p > .05; I 2 = 19.7%). However, as sources of heterogeneity should be explored even when the overall test for heterogeneity is not significant (Thompson & Higgins, 2002) , further moderator analyses were conducted. As was the case for glycaemic control, trials with higher standard care quality scores (>42) had a larger pooled effect size on psychological outcomes (d = .12, 95% CI: −.03 to .26) than those with lower standard care quality (d = −.04, 95% CI: −.29 to .21) (see Figure 6 ). Meta-regression analysis revealed a trend towards standard care quality as a predictor of effect size (t = 1.61, p = .158) when considered individually but this was not apparent when considered in models that included potentially confounding trial features. 
Discussion
Previous research has illustrated the importance of care quality delivered to control groups in determining effect sizes in RCTs of HIV antiretroviral adherence interventions (de Bruin et al., 2009 (de Bruin et al., , 2010 . In this study, we aimed to describe standard care reporting and provision in RCTs of behaviour change interventions for young people with type 1 diabetes and the implications for interpreting trial outcomes.
Our results demonstrate that the reporting of standard care in published RCTs of behaviour change interventions for young people with type 1 diabetes is limited, with many articles providing little or no details about what constitutes standard care. Details most frequently reported in published articles were service-level features (e.g. clinic type) rather than information about specific activities designed to change behaviour or improve outcomes. This suggests that little weight is given to describing standard care, in part, perhaps a response to word restrictions in publications, but also perhaps under the assumption that standard care does not differ across health centres. However, even given the limited descriptions in trials we assessed, there was considerable variation in standard care. There were differences in scheduled time intervals of routine appointments, staff involved and activities that were reported as part of standard care.
This variation in standard care was confirmed by authors' responses to a retrospective checklist of standard care activities. In line with the argument that poor reporting is partly a response to word restrictions in published articles, authors described a greater number of standard care activities than reported in published articles, with previously unreported behaviour change techniques often forming part of care. Standard care quality differed substantially between trials, a finding congruent with previous research (de Bruin et al., 2009) , suggesting that variation in standard care may well be the norm in clinical care for chronic conditions.
We also examined the effect of this variation on control group outcomes. Control groups receiving better standard care quality showed larger positive effect sizes than those with lower standard care quality for both glycaemic control and psychological outcomes. This would impact on effect sizes calculated for interventions; with those interventions compared against higher standard care quality appearing less effective than if they were compared against a lower quality standard care. However, when entered as a predictor in meta-regression analyses, standard care quality did not reach statistical significance. In part, this may be due to lack of power, given the relatively small number of interventions we identified for young people with type 1 diabetes. Furthermore, assuming most participants were receiving standard care prior to baseline measures, it is likely the changes captured by our effect sizes across the course of the trial only represent part of the overall influence of standard care.
Despite the inconclusive nature of our findings in terms of impact on control group outcomes, the evidence we present of substantial variation in standard care quality and limited reporting in RCTs is of considerable concern. Previous work has demonstrated the impact of standard care variation on effect sizes and the outcomes of meta-analyses (de Bruin et al., 2009 (de Bruin et al., , 2010 ) an issue which is compounded when reporting of standard care is poor. Despite recommendations that control conditions are described as fully as intervention conditions (Zwarenstein et al., 2008) it seems that in many cases the reporting of control conditions is demonstrably not a priority.
Strengths and limitations
We successfully adapted a checklist previously used to assess standard care quality in HIV antiretroviral adherence trials (de Bruin et al., 2009 ) and applied it to trials of behaviour change interventions for young people with type 1 diabetes. While the most significant amendment to the checklist involved rewording of items to be relevant for diabetes care, it is important to highlight a difference in terms of response options. In the original checklist, authors were asked to respond 'yes', 'no' or 'don't know'. In our version of the checklist, authors were asked to indicate which activities were routinely delivered using more differentiated response categories ('never'; 'for some patients'; 'for most patients'; 'for all patients'; and 'don't know'). Use of these more differentiated response categories has the potential advantage to capture when an activity is delivered to only some patients. However, given that many authors were necessarily recalling how standard care was delivered many years previously, we cannot be certain about the accuracy with which they were able to report such differences.
A further limitation of this method is that it relies on retrospective accounts of care, at the time of the trial, in some cases over a decade earlier. In addition, trial authors may not themselves have been personally involved in delivering standard care. Due to the limited nature of standard care reporting in trials it was not feasible to derive a standard care quality score from published articles. With improved reporting of standard care, future researchers will be able to assess standard care quality from published articles without needing to contact authors many years post-trial.
This study benefits from systematic searches, pre-determined inclusion criteria that help minimise selection bias and a high response rate from trial authors. We found our checklist for standard care quality to be internally reliable, suggesting the checklist itself captures an underlying factor, which could reasonably be described as the quality of diabetes standard care or adherence counselling. While many of the items were adapted from the checklist developed by de Bruin et al. (2009) , additional checklist items were derived in conjunction with informal discussions with consultants and diabetes nurses working in our centre. Further development of the checklist should include consultation with those working in other centres to ensure a comprehensive list of activities that may form part of standard care.
The checklist described in this paper was designed to assess if, and to what proportion of participants, activities are delivered as part of standard care. However, it does not give insight into how well some of these activities are employed (e.g. the quality/ extent of activities). Such an examination goes beyond the scope of this paper. However, we would argue that in future reporting, it is essential to include an improved description of standard care and some rationale for why each activity or technique is considered appropriate. Finally, authors should include, where possible, some examples of what each activity involved (e.g. types of goals set and plans made). Only in this way will we be able to assess which behaviour change techniques are being delivered as part of standard care and their role in the outcomes of RCTs.
Concluding remarks
RCTs are generally considered to represent the 'gold standard' when testing the efficacy of health behaviour change interventions (Coates, 2010) . This special issue of Psychology & Health explores the numerous biases that can potentially undermine or distort outcomes using this methodology and suggests ways to both acknowledge and/or mitigate them (e.g. de Bruin, McCambridge, & Prins, 2015) . In this paper, we have explored how poor reporting of standard care limits generalisabilty and potentially introduces bias. There is now ample evidence that standard care for chronic conditions is not uniform across trials. In the case of multi-centre trials, it is important that researchers establish that all participating centres conform to a basic standard care quality at the start of the trial and that any remaining differences between participating centres are adequately described.
We echo the call of de Bruin et al. (2009) that those conducting future RCTs give greater priority to describing what constitutes 'standard care' in their trial. At least for trials involving type 1 diabetes, the checklist developed in this study may be a useful tool in this regard. If authors decide against using this checklist in favour of prosebased descriptions, we recommend they at least use language similar to that used in the checklist as this allows for coding of behaviour change techniques. Written descriptions of standard care should extend beyond service-level details and focus on active components of care (e.g. behaviour change techniques). We acknowledge that space is often limited in published articles, yet detailed descriptions could be referenced and made available online. This call shares similarities with the recent focus on the need for improved reporting of intervention conditions in behaviour change interventions (Craig et al., 2008; Michie & Prestwich, 2010) . We argue, as have others (Bishop, Fenge-Davies, Kirby, & Geraghty, 2015; Williams, 2010) , that it is equally important to consider and describe the nature of the control group since this plays an integral role in evaluation of an RCT.
